6-oxopiperidine-2-carboxylic acid (6-oxoPIP)
Pretreatment with Roxadustat (FG-4592) attenuates folic acid-induced kidney injury through Antiferroptosis via Akt/GSK-3beta/Nrf2 pathway
[27] In pediatric cryptorchidism, dosing may range from 500 IU three times weekly for 3 weeks to 4,000 IU three times weekly for 6 weeks, based on clinical protocol
Enhanced NO Stability - Once NO is produced, glutathione acts as a powerful protector against oxidative damage
Ballas SK, Kesen MR, Goldberg MF, Lutty GA, Dampier C, Osunkwo I, Wang WC, Hoppe C, Hagar W, Darbari DS et al (2012) Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management
Cancer risk in people with a cancer history, because of NNMT's complex role in tumor biology